Trial Details
Not RecruitingBasic Information
| Clinical ID | c5068 |
|---|---|
| Identifier | EUCTR2019-002942-19-DK |
| Trial Title | NORDTREAT.The Nordic IBD treatment strategy trial a randomized controlled trial of access to a protein profile. |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NULL |
|---|---|
| Conditions | Crohn's disease and Ulcerative colitis MedDRA version: 20.1.Level: LLT.Classification code 10045365.Term: Ulcerative colitis.System Organ Class: 10017947 - Gastrointestinal disorders. MedDRA version: 20.0_x0 |
| Interventions | Trade Name: RemicadeInfliximabPharmaceutical Form: Powder for concentrate for solution for infusionINN or Proposed INN: INFLIXIMABCAS Number: 170277-31-3Concentration unit: mg milligram(s)Concentration type: equalConcentrat |
Participant Information
| Sponsor | Region ebro l |
|---|---|
| City | NULL |
| Country/Region | Denmark;Iceland |
Enrollment Criteria
| Sex Requirement | NOT SPECIFIED |
|---|---|
| Age Requirement | NULL |
Study Design
| Study Type | Interventional clinical trial of medicinal product |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | NULL |
|---|---|
| Primary Completion Date | NULL |
| Completion Date | NULL |